Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 09 February 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Predictors of columnar lined esophagus in GERD

A study in November's issue of the American Journal of Gastroenterology investigates the prevalence and predictors of columnar lined esophagus in GERD patients undergoing upper endoscopy.

News image

Chronic gastroesophageal reflux disease (GERD) is a risk factor for Barrett's esophagus, the most important surrogate marker for the development of esophageal adenocarcinoma.

The need to document the presence of intestinal metaplasia in esophageal biopsies from a columnar lined esophagus to diagnose Barrett's esophagus is debated.

Dr Prateek Sharma and colleagues from Missouri, USA prospectively evaluated the prevalence and risk factors of columnar lined esophagus in a large cohort of GERD patients undergoing upper endoscopy.

Consecutive patients presenting to the endoscopy unit at a tertiary referral center for their index upper endoscopy for evaluation of GERD symptoms were enrolled in this prospective cohort study.

Patients were asked to complete a validated GERD questionnaire that documents the onset of GERD symptoms, and grades the frequency and severity of symptoms experienced over the past year.

The prevalence of columnar lined esophagus was 23%
American Journal of Gastroenterology

Demographic information, body mass index, and use of aspirin/nonsteroidal antiinflammatory drugs were recorded.

The team evaluated endoscopic details including length of columnar lined esophagus, presence and size of hiatal hernia.

All factors that were statistically significant were then entered into stepwise logistic regression to evaluate for independent predictors of columnar lined esophagus.

The research team enrolled a total of 1058 patients with GERD symptoms.

On index endoscopy, the team found that the prevalence of columnar lined esophagus was 23%, whereas of columnar lined esophagus with documented intestinal metaplasia was 14%.

The research team observed that male gender, Caucasian race, heartburn duration of more than 5 years, presence and size of hiatal hernia were significantly associated with the presence of CLE compared with controls.

On further analysis, the team noted that heartburn duration more than 5 years, Caucasian race, and hiatal hernia were independent predictors for columnar lined esophagus.

The team found that columnar lined esophagus length was significantly associated with the presence of intestinal metaplasia.
 
Dr Sharma's team concludes, "If Barrett's esophagus is defined by the presence of columnar lined esophagus alone on upper endoscopy, up to 25% of GERD patients are diagnosed with this lesion."

"Enrolling all these patients in surveillance programs would have significant ramifications on health-care resources."

Am J Gastroenterol 2012; 107:1655–1661
23 November 2012

Go to top of page Email this page Email this page to a colleague

 09 February 2016 
Eosinophilic esophagitis and parental allergies
 09 February 2016 
Cancer-specific prognosis in octogenarians with colorectal cancer
 09 February 2016 
Bowel preparation for colonoscopy screening
 08 February 2016 
Immunity in the human gut
 08 February 2016 
Cancelled colonoscopy appointments
 08 February 2016 
Cognitive function in Crohn's disease
 05 February 2016 
Helicobacter cinaedi bacteremia
 05 February 2016 
Treatment for ileal pouch-anal anastomosis for Crohn’s colitis
 05 February 2016 
Methotrexate and remission in ulcerative colitis
 04 February 2016 
Diabetes and liver cancer
 04 February 2016 
Colorectal cancer screening
 04 February 2016 
H. pylori and coronary heart disease 
 03 February 2016 
Acute diverticulitis and IBS 
 03 February 2016 
Microbiota of the colonic mucosa and chronic constipation
 03 February 2016 
Guidelines for chronic pancreatitis
 02 February 2016 
Ramosetron and IBS-diarrhea
 02 February 2016 
IBD emergency department visits
 02 February 2016 
Probiotics for H. pylori management
 01 February 2016 
Managing HBV in pregnancy
 01 February 2016 
Obesity and hepatocellular carcinoma risk
 01 February 2016 
Depressive symptoms in IBD 
 29 January 2016 
Colorectal cancer after colonoscopy
 29 January 2016 
Acute diverticulitis in immunosuppressed patients
 29 January 2016 
Vitamin D and colorectal cancer risk
 28 January 2016 
Tissue anti-TNF drug levels and IBD
 28 January 2016 
First line treatment of H. pylori infection
 28 January 2016 
Tetracycline for rosacea increases the risk of IBD
 27 January 2016 
Steroids in children with Crohn's
 27 January 2016 
Self-management IBS program 
 27 January 2016 
Human gut microbiome in IBD 
 26 January 2016 
Smoking and symptomatic diverticular disease
 26 January 2016 
Step-down therapy in PPI-responsive esophageal eosinophilia 
 26 January 2016 
Diet and IBD risk
 25 January 2016 
IBD monitoring using smartphones
 25 January 2016 
Self-management IBS program
 25 January 2016 
Colorectal cancer after a negative screening sigmoidoscopy
 22 January 2016 
Length of Barrett's and cancer
 22 January 2016 
Psychosocial interventions and alcohol abstinence in chronic liver disease
 22 January 2016 
Helicobacter pylori antibiotic resistance
 21 January 2016 
Increasing adenoma detection rate during colonoscope withdrawal
 21 January 2016 
Microscopic colitis current concepts
 21 January 2016 
Statins as a management strategy for constipation 
 20 January 2016 
Health status after bariatric surgery
 20 January 2016 
Hep E infection in West Africa
 20 January 2016 
Preventing endoscopic bacterial transmission
 19 January 2016 
PPIs and phlebotomy in hereditary hemochromatosis
 19 January 2016 
Predicting liver cirrhosis in Hep C
 19 January 2016 
Frozen vs fresh fecal microbiota transplantation
 18 January 2016 
Hospitalization for diverticulitis in the USA
 18 January 2016 
H. pylori and gastric cancer across Europe
 18 January 2016 
Enteral nutrition in children with Crohn's
 15 January 2016 
Alcohol- and HCV-related hepatocellular carcinoma
 15 January 2016 
Recurrent colonic diverticulitis
 15 January 2016 
Colonic diverticula and colorectal cancer risk
 14 January 2016 
Risk stratification of incidentally discovered gallstones
 14 January 2016 
Treatment of refractory cholestatic pruritus
 14 January 2016 
Colonic diverticula and colorectal cancer risk 
 13 January 2016 
C-section delivery and IBD risk
 13 January 2016 
Primary biliary cholangitis treatment with incomplete UDCA response
 13 January 2016 
Colon cancer screening rates 

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us